Rtw Investments, LP Avidity Biosciences, Inc. Transaction History
Rtw Investments, LP
- $5.99 Billion
- Q2 2024
A detailed history of Rtw Investments, LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 8,806,838 shares of RNA stock, worth $373 Million. This represents 6.01% of its overall portfolio holdings.
Number of Shares
8,806,838
Previous 7,970,269
10.5%
Holding current value
$373 Million
Previous $203 Million
76.87%
% of portfolio
6.01%
Previous 3.26%
Shares
8 transactions
Others Institutions Holding RNA
# of Institutions
206Shares Held
95.5MCall Options Held
171KPut Options Held
196K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$462 Million0.05% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$365 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$275 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$252 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.4MShares$229 Million3.32% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.21B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...